92 related articles for article (PubMed ID: 3714756)
1. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
Yasky J; Ledesma GA; Tutera A; Collia LF
Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
[TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
Yasky J; Ledesma GA; Tutera A; Collia LF
Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
Bednarz B; Cybulski J; Chamiec T
Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
Freude J
MMW Munch Med Wochenschr; 1979 Jun; 121(24):827-30. PubMed ID: 111084
[TBL] [Abstract][Full Text] [Related]
7. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
Bachour G
Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
Mauersberger H; Rangoonwala B; Ehrlich E
Wien Med Wochenschr; 1985 Apr; 135(8):205-13. PubMed ID: 4013351
[TBL] [Abstract][Full Text] [Related]
9. The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
Viherkoski M; Huikko M; Varjoranta K
Ann Clin Res; 1981 Feb; 13(1):11-5. PubMed ID: 7018361
[TBL] [Abstract][Full Text] [Related]
10. An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.
Latta D; Finnamore VP; Dalton K; Allman S
J Int Med Res; 1990; 18 Suppl 2():10B-16B. PubMed ID: 2193839
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone use in patients with heart failure.
Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
[TBL] [Abstract][Full Text] [Related]
12. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
Allman S; Norris RJ
J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
[TBL] [Abstract][Full Text] [Related]
13. High-dose furosemide in the treatment of refractory congestive heart failure.
Gerlag PG; van Meijel JJ
Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836
[TBL] [Abstract][Full Text] [Related]
14. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
15. Diuretic and clinical effects of low-dose furosemide in congestive heart failure patients.
Mahabir RN; Bacchus R
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):510-7. PubMed ID: 789413
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
Cserhalmi L
Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
Levy B
J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
[TBL] [Abstract][Full Text] [Related]
18. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
Grosskopf I; Rabinovitz M; Rosenfeld JB
Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
[TBL] [Abstract][Full Text] [Related]
19. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Ishii C
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S19-22. PubMed ID: 12688391
[TBL] [Abstract][Full Text] [Related]
20. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
